Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Altemose G. T., Gritsus V., Jeevanandam V., Goldman B., Margulies K. B. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant. 1997 Jul;16(7):765–773. [PubMed] [Google Scholar]
- Anversa P., Kajstura J., Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol. 1996 May;11(3):245–251. doi: 10.1097/00001573-199605000-00004. [DOI] [PubMed] [Google Scholar]
- Benedict C. R. Neurohumoral aspects of heart failure. Cardiol Clin. 1994 Feb;12(1):9–23. [PubMed] [Google Scholar]
- Bonow R. O., Udelson J. E. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med. 1992 Sep 15;117(6):502–510. doi: 10.7326/0003-4819-117-6-502. [DOI] [PubMed] [Google Scholar]
- Bonow R. O., Vitale D. F., Bacharach S. L., Frederick T. M., Kent K. M., Green M. V. Asynchronous left ventricular regional function and impaired global diastolic filling in patients with coronary artery disease: reversal after coronary angioplasty. Circulation. 1985 Feb;71(2):297–307. doi: 10.1161/01.cir.71.2.297. [DOI] [PubMed] [Google Scholar]
- Cohn J. N., Levine T. B., Olivari M. T., Garberg V., Lura D., Francis G. S., Simon A. B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984 Sep 27;311(13):819–823. doi: 10.1056/NEJM198409273111303. [DOI] [PubMed] [Google Scholar]
- DeRose J. J., Jr, Umana J. P., Argenziano M., Catanese K. A., Gardocki M. T., Flannery M., Levin H. R., Sun B. C., Rose E. A., Oz M. C. Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. J Am Coll Cardiol. 1997 Dec;30(7):1773–1777. doi: 10.1016/s0735-1097(97)00396-3. [DOI] [PubMed] [Google Scholar]
- Ferguson D. W., Berg W. J., Sanders J. S., Roach P. J., Kempf J. S., Kienzle M. G. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation. 1989 Jul;80(1):65–77. doi: 10.1161/01.cir.80.1.65. [DOI] [PubMed] [Google Scholar]
- Frazier O. H., Benedict C. R., Radovancevic B., Bick R. J., Capek P., Springer W. E., Macris M. P., Delgado R., Buja L. M. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996 Sep;62(3):675–682. doi: 10.1016/s0003-4975(96)00437-7. [DOI] [PubMed] [Google Scholar]
- Frazier O. H., Macris M. P., Myers T. J., Duncan J. M., Radovancević B., Parnis S. M., Cooley D. A. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg. 1994 Jun;57(6):1416–1422. doi: 10.1016/0003-4975(94)90094-9. [DOI] [PubMed] [Google Scholar]
- Gheorghiade M., Bonow R. O. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation. 1998 Jan 27;97(3):282–289. doi: 10.1161/01.cir.97.3.282. [DOI] [PubMed] [Google Scholar]
- Gottlieb S. S., Kukin M. L., Ahern D., Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 1989 Jun;13(7):1534–1539. doi: 10.1016/0735-1097(89)90344-6. [DOI] [PubMed] [Google Scholar]
- Habib F. M., Springall D. R., Davies G. J., Oakley C. M., Yacoub M. H., Polak J. M. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 1996 Apr 27;347(9009):1151–1155. doi: 10.1016/s0140-6736(96)90610-8. [DOI] [PubMed] [Google Scholar]
- Haywood G. A., Tsao P. S., von der Leyen H. E., Mann M. J., Keeling P. J., Trindade P. T., Lewis N. P., Byrne C. D., Rickenbacher P. R., Bishopric N. H. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996 Mar 15;93(6):1087–1094. doi: 10.1161/01.cir.93.6.1087. [DOI] [PubMed] [Google Scholar]
- Heidenreich P. A., Lee T. T., Massie B. M. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1997 Jul;30(1):27–34. doi: 10.1016/s0735-1097(97)00104-6. [DOI] [PubMed] [Google Scholar]
- Katz A. M. The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart. Ann Intern Med. 1994 Sep 1;121(5):363–371. doi: 10.7326/0003-4819-121-5-199409010-00009. [DOI] [PubMed] [Google Scholar]
- Luppi P., Rudert W. A., Zanone M. M., Stassi G., Trucco G., Finegold D., Boyle G. J., Del Nido P., McGowan F. X., Jr, Trucco M. Idiopathic dilated cardiomyopathy: a superantigen-driven autoimmune disease. Circulation. 1998 Aug 25;98(8):777–785. doi: 10.1161/01.cir.98.8.777. [DOI] [PubMed] [Google Scholar]
- Marian A. J., Roberts R. Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death. J Cardiovasc Electrophysiol. 1998 Jan;9(1):88–99. doi: 10.1111/j.1540-8167.1998.tb00871.x. [DOI] [PubMed] [Google Scholar]
- Massin E. K. Outpatient management of congestive heart failure. Tex Heart Inst J. 1998;25(4):238–250. [PMC free article] [PubMed] [Google Scholar]
- McKay R. G., Pfeffer M. A., Pasternak R. C., Markis J. E., Come P. C., Nakao S., Alderman J. D., Ferguson J. J., Safian R. D., Grossman W. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986 Oct;74(4):693–702. doi: 10.1161/01.cir.74.4.693. [DOI] [PubMed] [Google Scholar]
- Mestroni L., Giacca M. Molecular genetics of dilated cardiomyopathy. Curr Opin Cardiol. 1997 May;12(3):303–309. doi: 10.1097/00001573-199705000-00012. [DOI] [PubMed] [Google Scholar]
- Müller J., Wallukat G., Weng Y. G., Dandel M., Spiegelsberger S., Semrau S., Brandes K., Theodoridis V., Loebe M., Meyer R. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997 Jul 15;96(2):542–549. doi: 10.1161/01.cir.96.2.542. [DOI] [PubMed] [Google Scholar]
- Packer M., Bristow M. R., Cohn J. N., Colucci W. S., Fowler M. B., Gilbert E. M., Shusterman N. H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996 May 23;334(21):1349–1355. doi: 10.1056/NEJM199605233342101. [DOI] [PubMed] [Google Scholar]
- Pennington D. G., McBride L. R., Peigh P. S., Miller L. W., Swartz M. T. Eight years' experience with bridging to cardiac transplantation. J Thorac Cardiovasc Surg. 1994 Feb;107(2):472–481. [PubMed] [Google Scholar]
- Pitt B., Segal R., Martinez F. A., Meurers G., Cowley A. J., Thomas I., Deedwania P. C., Ney D. E., Snavely D. B., Chang P. I. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Lancet. 1997 Mar 15;349(9054):747–752. doi: 10.1016/s0140-6736(97)01187-2. [DOI] [PubMed] [Google Scholar]
- Roberts R., Marian A. J., Bachinski L. Molecular genetics of hypertrophic cardiomyopathy. J Card Fail. 1996 Dec;2(4 Suppl):S87–S95. doi: 10.1016/s1071-9164(96)80063-7. [DOI] [PubMed] [Google Scholar]
- Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J. B., Mann D. L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996 Apr;27(5):1201–1206. doi: 10.1016/0735-1097(95)00589-7. [DOI] [PubMed] [Google Scholar]
- Wei C. M., Lerman A., Rodeheffer R. J., McGregor C. G., Brandt R. R., Wright S., Heublein D. M., Kao P. C., Edwards W. D., Burnett J. C., Jr Endothelin in human congestive heart failure. Circulation. 1994 Apr;89(4):1580–1586. doi: 10.1161/01.cir.89.4.1580. [DOI] [PubMed] [Google Scholar]
